Position in DYN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,556,415
-$760,958 QoQ
Shares Held
115,102
-37.1% QoQ
Ownership
0.062%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#94
of 245 holders
Holding Since
Sep 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DYN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Rafferty Asset Management, LLC holds $331,711,589 across 163 Biotechnology names. DYN ranks #49 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
65,798 | $32,683,840 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
38,534 | $24,027,490 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
55,332 | $16,656,591 | |
| 4 | MRNA |
Moderna, Inc.
|
111,906 | $7,836,777 | |
| 5 | INCY |
Incyte Corp
|
44,663 | $5,062,997 | |
| 6 | APGE |
Apogee Therapeutics, Inc.
|
33,369 | $4,429,067 | |
| 7 | ORKA |
Oruka Therapeutics, Inc.
|
43,110 | $4,102,778 | |
| 8 | KYMR |
Kymera Therapeutics, Inc.
|
35,287 | $4,046,360 |
All Filings in DYN
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,556,415 | 115,102 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $3,317,373 | 182,977 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $4,573,812 | 233,835 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,697,119 | 213,211 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,049,560 | 110,248 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,541,312 | 147,353 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $3,945,875 | 167,482 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $5,925,435 | 164,962 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $5,130,389 | 145,378 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $9,777,260 | 344,391 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $2,181,745 | 164,041 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $1,249,104 | 139,409 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,319,220 | 117,264 | Shares | Sole | 2023-08-11 | |
| 2022-12-31 | $164,473 | 14,191 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $268,325 | 21,128 | Shares | Sole | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||